Clinical trial
A Study for Patients With Head and Neck Cancer
NCT00415194 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00415194 |
|---|---|
| Title | A Study for Patients With Head and Neck Cancer |
| Official title | A Randomized Phase 3 Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Monotherapy in Patients With Recurrent or Metastatic Head and Neck Cancer |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Head and Neck Neoplasms |
| Intervention type | Drug |
| Interventions | pemetrexed, cisplatin, placebo |
| Enrollment | 795 |
| Start date | Dec 1, 2006 |
| Primary completion | Mar 1, 2010 |
| Completion | Mar 1, 2010 |
| First posted | Dec 22, 2006 |
| Last update posted | Jun 28, 2011 |
| Countries | Argentina, Belgium, Brazil, China, Denmark, France, Germany, Hungary, India, Italy, Mexico, Netherlands and 9 more |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: